These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28336631)

  • 1. Patent pools for CRISPR technology.
    Horn L
    Science; 2017 Mar; 355(6331):1274. PubMed ID: 28336631
    [No Abstract]   [Full Text] [Related]  

  • 2. Patent pools for CRISPR technology-Response.
    Contreras JL; Sherkow JS
    Science; 2017 Mar; 355(6331):1274-1275. PubMed ID: 28336632
    [No Abstract]   [Full Text] [Related]  

  • 3. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dealing with Patent Fragmentation in Genetics: Can Patent Pools Facilitate the Development of CRISPR Gene-Editing Technology?
    Stasi A; Rodrigues IP
    J Law Med; 2019 Jul; 26(4):866-873. PubMed ID: 31682364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assembling the Streptococcus thermophilus clustered regularly interspaced short palindromic repeats (CRISPR) array for multiplex DNA targeting.
    Guo L; Xu K; Liu Z; Zhang C; Xin Y; Zhang Z
    Anal Biochem; 2015 Jun; 478():131-3. PubMed ID: 25748774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
    Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
    BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of CRISPR-Cas systems in neuroscience.
    Heidenreich M; Zhang F
    Nat Rev Neurosci; 2016 Jan; 17(1):36-44. PubMed ID: 26656253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editing and investigating genomes with TALE and CRISPR/Cas systems: applications of artificial TALE and CRISPR-Cas systems.
    Giovannangeli C; Concordet JP
    Methods; 2014 Sep; 69(2):119-20. PubMed ID: 25248487
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing CRISPR-Cas systems for bacterial genome editing.
    Selle K; Barrangou R
    Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR adaptation in Escherichia coli subtypeI-E system.
    Kiro R; Goren MG; Yosef I; Qimron U
    Biochem Soc Trans; 2013 Dec; 41(6):1412-5. PubMed ID: 24256229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular signaling in CRISPR-Cas defense.
    Amitai G; Sorek R
    Science; 2017 Aug; 357(6351):550-551. PubMed ID: 28798118
    [No Abstract]   [Full Text] [Related]  

  • 13. SnapShot: Class 1 CRISPR-Cas Systems.
    Makarova KS; Zhang F; Koonin EV
    Cell; 2017 Feb; 168(5):946-946.e1. PubMed ID: 28235204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotechnology: CRISPR-Cas becoming more human.
    Baumann K
    Nat Rev Drug Discov; 2017 Sep; 16(9):601. PubMed ID: 28860585
    [No Abstract]   [Full Text] [Related]  

  • 15. [The application of CRISPR/Cas9 genome editing technology in cancer research].
    Wang DY; Ma N; Hui Y; Gao X
    Yi Chuan; 2016 Jan; 38(1):1-8. PubMed ID: 26787518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
    Mashimo T
    Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technique: Transcript tracking by CRISPR.
    Burgess DJ
    Nat Rev Genet; 2016 May; 17(5):254-5. PubMed ID: 27040488
    [No Abstract]   [Full Text] [Related]  

  • 18. CRISPR-Cas Systems in Prokaryotes.
    Burmistrz M; Pyrć K
    Pol J Microbiol; 2015; 64(3):193-202. PubMed ID: 26638527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The New Genetic Frontier: CRISPR-Cas9?
    Hansen K
    S D Med; 2017 Jun; 70(6):245. PubMed ID: 28813758
    [No Abstract]   [Full Text] [Related]  

  • 20. The CRISPR Growth Spurt: from Bench to Clinic on Versatile Small RNAs.
    Bayat H; Omidi M; Rajabibazl M; Sabri S; Rahimpour A
    J Microbiol Biotechnol; 2017 Feb; 27(2):207-218. PubMed ID: 27840399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.